Entheon Biomedical
  • CSE:ENBI
  • OTC:ENTBF
  • ABOUT ENTHEON
  • REASONS TO BELIEVE
  • TEAM
  • INVESTORS
    • SHARE STRUCTURE
    • STOCK INFORMATION
    • FINANCIAL STATEMENTS
    • PRESS RELEASES & NEWS
  • CONTACT
Select Page
Entheon Biomedical Announces Corporate Update Including Investment in Wonder Scientific

Entheon Biomedical Announces Corporate Update Including Investment in Wonder Scientific

by Entheogen Biomedical | Dec 4, 2020 | Company News

Originally published at https://www.newsfilecorp.com/release/69518 Vancouver, BC – December 4, 2020 – Entheon Biomedical Corp. (CSE: “ENBI”) (FSE:1XU1) (“Entheon” or the “Company”), a biotechnology company focused on developing psychedelic medicines to treat...
Entheon Biomedical Announces CRO Agreement with CHDR for Phase 1 Clinical Trial

Entheon Biomedical Announces CRO Agreement with CHDR for Phase 1 Clinical Trial

by Entheogen Biomedical | Dec 1, 2020 | Company News

Centre for Human Drug Research led DMT study to start in 2021 Vancouver, BC – December 1, 2020 – Entheon Biomedical Corp. (“Entheon” or the “Company”) (CSE: ENBI) (FSE: 1XU1), a biotechnology company focused on developing psychedelic medicines to treat...
Entheon Announces Completion of Amalgamation and Final Approval from the Canadian Securities Exchange

Entheon Announces Completion of Amalgamation and Final Approval from the Canadian Securities Exchange

by Entheogen Biomedical | Nov 6, 2020 | Company News

Original Source – Newsfile Corp. Vancouver, British Columbia–(Newsfile Corp. – November 5, 2020) – Entheon Biomedical Corp. (CSE: MPV) (formerly, MPV Exploration Inc.) (“Entheon” or the “Company”) is pleased to announce...
MPV annonce l’approbation conditionnelle de sa transaction avec Entheon Biomedical Corp. par le CSE

MPV annonce l’approbation conditionnelle de sa transaction avec Entheon Biomedical Corp. par le CSE

by Entheogen Biomedical | Oct 28, 2020 | Company News

MONTRÉAL, 28 oct. 2020 (GLOBE NEWSWIRE) — Exploration MPV Inc. (« MPV » ou la « Société ») est heureuse d’annoncer que suite à ses communiqués de presse datées du 2 juillet 2020 et du 10 septembre 2020 (les « communiqués de presse initiaux »...
MPV annonce l’approbation conditionnelle de sa transaction avec Entheon Biomedical Corp. par le CSE

MPV announces CSE’s conditional approval of its transaction with Entheon Biomedical Corp.

by Entheogen Biomedical | Oct 28, 2020 | Company News

MONTREAL, Oct. 28, 2020 (GLOBE NEWSWIRE) — MPV Exploration Inc. (“MPV” or the “Company”) is pleased to announce that further to its news releases dated July 2, 2020 and September 10, 2020 (the “Initial News Releases”), the Company has...
Psychedelics and Their Place in Modern Pharmacology, a Q&A with Andrew Hegle, Ph.D.

Psychedelics and Their Place in Modern Pharmacology, a Q&A with Andrew Hegle, Ph.D.

by Entheogen Biomedical | Sep 21, 2020 | Company News

Dr. Andrew Hegle currently serves as Entheon Biomedical’s Director of Operations. He has been an adjunct professor of Pharmacology at the University of British Columbia since 2015. He has a background in molecular biology and biochemistry and has published...
« Older Entries

Recent Posts

  • Entheon Biomedical Announces Corporate Update Including Investment in Wonder Scientific
  • Entheon Biomedical Announces CRO Agreement with CHDR for Phase 1 Clinical Trial
  • Entheon Announces Completion of Amalgamation and Final Approval from the Canadian Securities Exchange
  • When Will Psychedelics be Legal in the United States?
  • MPV annonce l’approbation conditionnelle de sa transaction avec Entheon Biomedical Corp. par le CSE

Recent Comments

    Archives

    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • June 2020
    • May 2020
    • April 2020
    • February 2020
    • December 2019
    • November 2019
    • July 2019
    • April 2019
    • December 2018
    • February 2018
    • January 2018

    Categories

    • Company News
    • Industry News
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Entheon Biomedical 2020 © All rights reserved | Website by S3 Communications | Terms & Privacy